Probiotic Blend for Celiac Disease
Celiac Disease
About this trial
This is an interventional treatment trial for Celiac Disease focused on measuring probiotic, gastrointestinal symptoms, life quality
Eligibility Criteria
Inclusion Criteria: Provision of Free and Informed Consent in writing, signed and dated; Age according to the indicated population; Patients diagnosed with celiac disease by a specialist physician. Exclusion Criteria: History of daily consumption of probiotics, fermented milk and or yogurt; subjects known to have demonstrated a prior reaction, including anaphylaxis, to any substance in the composition of the study product; Subjects who have uncompensated blood pressure; history of heart disease, including valvular heart disease or any implantable device; subjects with active, uncontrolled bowel disease such as Crohn's disease or ulcerative colitis; another clinical trial.
Sites / Locations
- Universidade do Extremo Sul CatarinenseRecruiting
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Placebo
Treatment
vehicle only - Maltodextrin gluten free
Bifidobacterium longum CCT 1934; Bifidobacterium lactis CCT 7858; Lactobacillus rhamnosus CCT 7863; Streptococcus thermophilus ATCC 19258) Final concentration: 1 x 10e10 CFU/ day